The Chhatrapati Shivaji Maharaj International Airport on Tursday said that it would soon launch India’s largest temperature controlled solution for the transportation of pharmaceuticals on the tarmac.
The GVK-led Mumbai International Airport Limited (MIAL), which became the first airport in India and third in Asia to achieve the International Air Transport Association’s Center of Excellence for Independent Validators in Pharmaceutical Logistics (IATA CEIV) certification, said that temperature-controlled solution will help prevent temperature excursions of pharma products during air transport with the key objective of patient safety and reduction of losses attributed to logistical issues.
The ‘IATA CEIV’ certification is an industry recognition, supporting the air transport industry to comply with pharmaceutical manufacturers’ requirements. A MIAL spokesperson said the Mumbai international airport had achieved this quality milestone for pharma logistics following training courses, on-site assessment, and complex validation processes. “Acknowledging the importance of this initiative, MIAL has initiated the certification process in a community approach together with its air cargo supply chain partners,” the spokesperson said.
Apart from being awarded this key accreditation, MIAL is now also a strategic member of ‘Pharma Aero’ and the project lead for ‘Airside Transport Benchmark,’ which will launch India’s largest temperature controlled solution for transportation of pharmaceuticals on the tarmac being introduced soon.
The IATA CEIV aims to improve the handling of pharmaceutical cargo by complying with existing national and international regulations. “The authorization ensures adequately equipped facilities, safety and security, standardisation and transparency across the air transport supply chain,” the spokesperson said.
